Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis by Seini Moimoi | Nov 20, 2019 | Portfolio News
Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications by Seini Moimoi | Nov 14, 2019 | Portfolio News
Tricidia Announces FDA Acceptance of New Drug Application for Veverimer by Seini Moimoi | Nov 14, 2019 | Portfolio News
Nabriva Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights by Seini Moimoi | Nov 12, 2019 | Portfolio News
Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results by Seini Moimoi | Nov 12, 2019 | Portfolio News
